Co-Authors
This is a "connection" page, showing publications co-authored by DAVID SANGHYUN HONG and BRIAN PAUL HOBBS.
Connection Strength
1.273
-
Basket Trials: Review of Current Practice and Innovations for Future Trials. J Clin Oncol. 2022 10 20; 40(30):3520-3528.
Score: 0.208
-
Investigating the natural history and prognostic nature of NTRK gene fusions in solid tumors. Invest New Drugs. 2022 02; 40(1):157-162.
Score: 0.197
-
Histology-agnostic drug development - considering issues beyond the tissue. Nat Rev Clin Oncol. 2020 09; 17(9):555-568.
Score: 0.182
-
Basket Designs: Statistical Considerations for Oncology Trials. JCO Precis Oncol. 2019 Dec; 3:1-9.
Score: 0.176
-
Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology. J Natl Cancer Inst. 2019 02 01; 111(2):118-128.
Score: 0.166
-
Statistical challenges posed by uncontrolled master protocols: sensitivity analysis of the vemurafenib study. Ann Oncol. 2018 12 01; 29(12):2296-2301.
Score: 0.164
-
Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations. Contemp Clin Trials Commun. 2022 Dec; 30:101000.
Score: 0.053
-
Moving Beyond 3+3: The Future of Clinical Trial Design. Am Soc Clin Oncol Educ Book. 2021 Jun; 41:e133-e144.
Score: 0.049
-
Quantification of the Effect of Shuttling on Computed Tomography Perfusion Parameters by Investigation of Aortic Inputs on Different Table Positions From Shuttle-Mode Scans of Lung and Liver Tumors. J Comput Assist Tomogr. 2018 May/Jun; 42(3):357-364.
Score: 0.039
-
Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer. Sci Rep. 2018 01 31; 8(1):1922.
Score: 0.039